2024-11-15 09:48:27
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US
Health/ 2023-07-22
Ascentage Pharma to Initiate Phase Ib St...

SUZHOU,China and ROCKVILLE,Md.,July 22,2019--Ascentage Pharma,a globally-focused,clinical-stage biotechnology company engaged in developing ...

Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center
Corporate/ 2023-07-23
Kazia to test GDC-0084 with Radiotherapy...

SYDNEY,July 22,2019-- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA),an Australian oncology-focused biotechnology company,is pleased to...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release